Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 179

1.

Use of a medically supervised injection facility among street youth.

Hadland SE, DeBeck K, Kerr T, Nguyen P, Simo A, Montaner JS, Wood E.

J Adolesc Health. 2014 Nov;55(5):684-9. doi: 10.1016/j.jadohealth.2014.04.013. Epub 2014 Jun 9.

2.

Use of North America's first medically supervised safer injecting facility among HIV-positive injection drug users.

Reddon H, Wood E, Tyndall M, Lai C, Hogg R, Montaner J, Kerr T.

AIDS Educ Prev. 2011 Oct;23(5):412-22. doi: 10.1521/aeap.2011.23.5.412.

3.

Nurse-delivered safer injection education among a cohort of injection drug users: evidence from the evaluation of Vancouver's supervised injection facility.

Wood RA, Wood E, Lai C, Tyndall MW, Montaner JS, Kerr T.

Int J Drug Policy. 2008 Jun;19(3):183-8. doi: 10.1016/j.drugpo.2008.01.003. Epub 2008 Mar 26.

PMID:
18367389
4.

The potential public health and community impacts of safer injecting facilities: evidence from a cohort of injection drug users.

Wood E, Kerr T, Spittal PM, Li K, Small W, Tyndall MW, Hogg RS, O'Shaughnessy MV, Schechter MT.

J Acquir Immune Defic Syndr. 2003 Jan 1;32(1):2-8.

PMID:
12514408
5.

Willingness to access an in-hospital supervised injection facility among hospitalized people who use illicit drugs.

Ti L, Buxton J, Harrison S, Dobrer S, Montaner J, Wood E, Kerr T.

J Hosp Med. 2015 May;10(5):301-6. doi: 10.1002/jhm.2344. Epub 2015 Mar 5.

6.

Circumstances of first injection among illicit drug users accessing a medically supervised safer injection facility.

Kerr T, Tyndall MW, Zhang R, Lai C, Montaner JS, Wood E.

Am J Public Health. 2007 Jul;97(7):1228-30. Epub 2007 May 30.

7.

Condom use among injection drug users accessing a supervised injecting facility.

Marshall BD, Wood E, Zhang R, Tyndall MW, Montaner JS, Kerr T.

Sex Transm Infect. 2009 Apr;85(2):121-6. doi: 10.1136/sti.2008.032524. Epub 2008 Sep 23.

PMID:
18812391
8.

Risk factors for developing a cutaneous injection-related infection among injection drug users: a cohort study.

Lloyd-Smith E, Wood E, Zhang R, Tyndall MW, Montaner JS, Kerr T.

BMC Public Health. 2008 Dec 9;8:405. doi: 10.1186/1471-2458-8-405.

9.

Do supervised injecting facilities attract higher-risk injection drug users?

Wood E, Tyndall MW, Li K, Lloyd-Smith E, Small W, Montaner JS, Kerr T.

Am J Prev Med. 2005 Aug;29(2):126-30.

PMID:
16005809
10.

Reduction in overdose mortality after the opening of North America's first medically supervised safer injecting facility: a retrospective population-based study.

Marshall BD, Milloy MJ, Wood E, Montaner JS, Kerr T.

Lancet. 2011 Apr 23;377(9775):1429-37. doi: 10.1016/S0140-6736(10)62353-7. Epub 2011 Apr 15.

PMID:
21497898
11.

Use of supervised injection facilities and injection risk behaviours among young drug injectors.

Bravo MJ, Royuela L, De la Fuente L, Brugal MT, Barrio G, Domingo-Salvany A; Itínere Project Group.

Addiction. 2009 Apr;104(4):614-9. doi: 10.1111/j.1360-0443.2008.02474.x. Epub 2009 Feb 10.

PMID:
19215603
12.

Attendance, drug use patterns, and referrals made from North America's first supervised injection facility.

Tyndall MW, Kerr T, Zhang R, King E, Montaner JG, Wood E.

Drug Alcohol Depend. 2006 Jul 27;83(3):193-8. Epub 2005 Dec 13.

PMID:
16356659
13.
14.

Prevalence and correlates of hepatitis C infection among users of North America's first medically supervised safer injection facility.

Wood E, Kerr T, Stoltz J, Qui Z, Zhang R, Montaner JS, Tyndall MW.

Public Health. 2005 Dec;119(12):1111-5. Epub 2005 Oct 7.

PMID:
16214189
15.

Non-fatal overdose among a cohort of active injection drug users recruited from a supervised injection facility.

Milloy MJ, Kerr T, Mathias R, Zhang R, Montaner JS, Tyndall M, Wood E.

Am J Drug Alcohol Abuse. 2008;34(4):499-509. doi: 10.1080/00952990802122457.

PMID:
18584579
16.

Injection drug use among street-involved youth in a Canadian setting.

Kerr T, Marshall BD, Miller C, Shannon K, Zhang R, Montaner JS, Wood E.

BMC Public Health. 2009 Jun 3;9:171. doi: 10.1186/1471-2458-9-171.

18.

Changes in injecting practices associated with the use of a medically supervised safer injection facility.

Stoltz JA, Wood E, Small W, Li K, Tyndall M, Montaner J, Kerr T.

J Public Health (Oxf). 2007 Mar;29(1):35-9. Epub 2007 Jan 17.

PMID:
17229788
19.

Unsafe injection practices in a cohort of injection drug users in Vancouver: could safer injecting rooms help?

Wood E, Tyndall MW, Spittal PM, Li K, Kerr T, Hogg RS, Montaner JS, O'Shaughnessy MV, Schechter MT.

CMAJ. 2001 Aug 21;165(4):405-10.

20.

Injection drug users' perceptions regarding use of a medically supervised safer injecting facility.

Petrar S, Kerr T, Tyndall MW, Zhang R, Montaner JS, Wood E.

Addict Behav. 2007 May;32(5):1088-93. Epub 2006 Aug 22.

PMID:
16930849

Supplemental Content

Support Center